Michigan Medicine: Itaconate Identified as a New Target for Pediatric Brain Tumors Called Ependymomas
February 07, 2026
February 07, 2026
ANN ARBOR, Michigan, Feb. 7 (TNSjou) -- Michigan Medicine, the academic medical center of the University of Michigan, issued the following news release:
* * *
Itaconate identified as a new target for pediatric brain tumors called ependymomas
Normally produced by immune cells, itaconate drives the development of ependymomas
*
Ependymomas are tumors that grow in the brain or spinal cord and are the third-most common type of brain tum . . .
* * *
Itaconate identified as a new target for pediatric brain tumors called ependymomas
Normally produced by immune cells, itaconate drives the development of ependymomas
*
Ependymomas are tumors that grow in the brain or spinal cord and are the third-most common type of brain tum . . .